Courtney Marabella | Authors


Poor Accuracy Seen with Standard IHC in Identifying Low HER2 Expression in Breast Cancer

December 08, 2021

Data presented at the San Antonio Breast Cancer Sympsium found that in patients with a low HER2 immunohistochemistry (IHC) score of 0 or 1+, poor agreement in the evaluation of these patients exist using standard HER2 assays.

CASPIAN Update Shows Continued Benefit of Durvalumab/Chemotherapy in ES-SCLC

September 21, 2021

In patients with extensive-stage small cell lung cancer, durvalumab added to platinum/etoposide chemotherapy continued to demonstrate an overall survival improvement compared with chemotherapy alone with a favorable safety profile, according to updated data from the phase 3 CASPIAN trial.